Adaptive Biotechnologies Corp vs Logitech International SA — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Logitech International SA trades at $103.82 (market cap $14.96B). The key difference: Logitech International SA is far larger — about 3.7× Adaptive Biotechnologies Corp's market cap, and Logitech International SA pays a 1.64% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LOGI | |
|---|---|---|
Market Cap | $4.04B | $14.96B |
Sector | Health | Technology |
52-Week High | $25.45 | $126.69 |
52-Week Low | $12.30 | $85.84 |
Enterprise Value | $4.10B | $13.30B |
Dividend Yield | — | 1.64% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →